Literature DB >> 30392065

Defragmentation of lysozyme derived Amyloid β fibril using Biocompatible Magnetic fluid.

Nidhi P Parikh1, Kinnari H Parekh2.   

Abstract

We present here a modulating effect on lysozyme derived Amyloid β fibrils by aqueous magnetic fluid. This non-conventional approach of treatment of lysozyme derived Amyloid β fibrils showed lysing of Amyloid fibrils to its secondary structures which can be seen using optical microscope and scanning electron microscopic image. The size of lysozyme derived amyloid fibrils before and after treatment was measured using dynamic light scattering technique. The mechanism of defragmentation of lysozyme derived Amyloid β fibrils by magnetic fluid is explained. This is a first report to identify the secondary structure of protein using Fourier Transform Infrared (FTIR) and Circular Dichroism (CD) spectra after lysing. The cyto-toxicity study of this magnetic fluid on neuronal (SH-SY5Y) and non-neuronal (NRK) cell lines shows non-toxicity up to a concentration of 250 μg/mL. The study indicates a novel and unique complementary approach to treat the amyloidogenic brain diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30392065     DOI: 10.1007/s10856-018-6185-7

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  25 in total

Review 1.  Gelatin as a delivery vehicle for the controlled release of bioactive molecules.

Authors:  Simon Young; Mark Wong; Yasuhiko Tabata; Antonios G Mikos
Journal:  J Control Release       Date:  2005-11-02       Impact factor: 9.776

2.  Using circular dichroism spectra to estimate protein secondary structure.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

3.  Immunogenicity of bioactive magnetic nanoparticles: natural and acquired antibodies.

Authors:  Ofra Ziv; Ramy R Avtalion; Shlomo Margel
Journal:  J Biomed Mater Res A       Date:  2008-06-15       Impact factor: 4.396

4.  EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity.

Authors:  Jan Bieschke; Jenny Russ; Ralf P Friedrich; Dagmar E Ehrnhoefer; Heike Wobst; Katja Neugebauer; Erich E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

5.  Alzheimer's disease: Attack on amyloid-β protein.

Authors:  Eric M Reiman
Journal:  Nature       Date:  2016-09-01       Impact factor: 49.962

6.  Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model.

Authors:  Elizabeth Joachim; Il-Doo Kim; Yinchuan Jin; Kyekyoon Kevin Kim; Ja-Kyeong Lee; Hyungsoo Choi
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

7.  TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.

Authors:  Wei-Hui Wu; Xun Sun; Ye-Ping Yu; Jia Hu; Lei Zhao; Qian Liu; Yu-Fen Zhao; Yan-Mei Li
Journal:  Biochem Biophys Res Commun       Date:  2008-06-20       Impact factor: 3.575

Review 8.  Polysaccharides-based nanoparticles as drug delivery systems.

Authors:  Zonghua Liu; Yanpeng Jiao; Yifei Wang; Changren Zhou; Ziyong Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-09-17       Impact factor: 15.470

9.  Effect of Fe(3)O(4) magnetic nanoparticles on lysozyme amyloid aggregation.

Authors:  Andrea Bellova; Eva Bystrenova; Martina Koneracka; Peter Kopcansky; Francesco Valle; Natalia Tomasovicova; Milan Timko; Jaroslava Bagelova; Fabio Biscarini; Zuzana Gazova
Journal:  Nanotechnology       Date:  2010-01-11       Impact factor: 3.874

10.  Nucleation of protein fibrillation by nanoparticles.

Authors:  Sara Linse; Celia Cabaleiro-Lago; Wei-Feng Xue; Iseult Lynch; Stina Lindman; Eva Thulin; Sheena E Radford; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.